Targeted Therapies in Oncology

July 2019
Volume: 8
Issue: 9

July 2
Volume: 8
Issue: 10

June 2019
Volume: 8
Issue: 8

May 2019
Volume: 8
Issue: 7

April 2 2019
Volume: 8
Issue: 6

April 2019
Volume: 8
Issue: 5

March 2019
Volume: 8
Issue: 4

February 2 2019
Volume: 8
Issue: 3

February 2019
Volume: 8
Issue: 2

January 2019
Volume: 8
Issue: 1

December 2 2018
Volume: 7
Issue: 13

December 2018
Volume: 7
Issue: 12

November 2018
Volume: 7
Issue: 11

October 2018
Volume: 7
Issue: 10

Sept 2018
Volume: 7
Issue: 9

August 2018
Volume: 7
Issue: 8

July 2018
Volume: 7
Issue: 7

June 2018
Volume: 7
Issue: 6

May 2018
Volume: 7
Issue: 5

April 2018
Volume: 7
Issue: 4

March 2018
Volume: 7
Issue: 3

February 2018
Volume: 7
Issue: 2

January 2018
Volume: 7
Issue: 1

December 2017
Volume: 6
Issue: 12

November 2017
Volume: 6
Issue: 11

October 2017
Volume: 6
Issue: 10

September 2017
Volume: 6
Issue: 9

August 2017
Volume: 6
Issue: 8

July 2017
Volume: 6
Issue: 7

June 2017
Volume: 6
Issue: 6
Advertisement
Advertisement
Trending on Targeted Onc
1
Galinpepimut-S Improves Overall Survival in Phase 3 REGAL Trial in AML
2
FDA Approves Neladalkib for Previously Treated Advanced ALK-Positive NSCLC
3
FDA Fast Tracks Elticertinib for Previously Treated EGFR Exon 20 NSCLC
4
Oncologists Weigh Age and Drug Interactions in mHSPC Treatment Selection
5
